Cyclin-dependent kinase inhibitor p16INK4a and telomerase may co-modulate endothelial progenitor cells senescence

[1]  M. Satoh,et al.  Association between oxidative DNA damage and telomere shortening in circulating endothelial progenitor cells obtained from metabolic syndrome patients with coronary artery disease. , 2008, Atherosclerosis.

[2]  B. Williams,et al.  Angiotensin II–Mediated Oxidative DNA Damage Accelerates Cellular Senescence in Cultured Human Vascular Smooth Muscle Cells via Telomere-Dependent and Independent Pathways , 2008, Circulation research.

[3]  A. Cheung,et al.  Telomere dysfunction, genome instability and cancer. , 2008, Frontiers in bioscience : a journal and virtual library.

[4]  J. Bartek,et al.  DNA damage signalling guards against activated oncogenes and tumour progression , 2007, Oncogene.

[5]  M. Malumbres,et al.  Genetic cooperation between p21Cip1 and INK4 inhibitors in cellular senescence and tumor suppression , 2007, Oncogene.

[6]  Jian-Mei Li,et al.  Cross-talk between aldosterone and angiotensin II in vascular smooth muscle cell senescence. , 2007, Cardiovascular research.

[7]  S. Artandi,et al.  Telomere uncapping in progenitor cells with critical telomere shortening is coupled to S-phase progression in vivo , 2007, Proceedings of the National Academy of Sciences.

[8]  Ronald A. DePinho,et al.  How stem cells age and why this makes us grow old , 2007, Nature Reviews Molecular Cell Biology.

[9]  T. Lange,et al.  Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1 , 2007, Nature.

[10]  R. Langer,et al.  Endothelial potential of human embryonic stem cells. , 2007, Blood.

[11]  G. Ertl,et al.  Differential Effects of Organic Nitrates on Endothelial Progenitor Cells Are Determined by Oxidative Stress , 2007 .

[12]  M. Sumi,et al.  Reconstituted High-Density Lipoprotein Stimulates Differentiation of Endothelial Progenitor Cells and Enhances Ischemia-Induced Angiogenesis , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[13]  P. Poole‐Wilson,et al.  Age-Dependent Impairment of Endothelial Progenitor Cells Is Corrected by Growth Hormone Mediated Increase of Insulin-Like Growth Factor-1 , 2007, Circulation research.

[14]  C. Zhu,et al.  Ginkgo Biloba Extract Reduces Endothelial Progenitor-Cell Senescence Through Augmentation of Telomerase Activity , 2007, Journal of cardiovascular pharmacology.

[15]  Dimitris Kletsas,et al.  Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints , 2006, Nature.

[16]  K. Ligon,et al.  p16INK4a induces an age-dependent decline in islet regenerative potential , 2006, Nature.

[17]  R. DePinho,et al.  Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a , 2006, Nature.

[18]  J. Campisi,et al.  Ageing: Balancing regeneration and cancer , 2006, Nature.

[19]  S. Morrison,et al.  Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing , 2006, Nature.

[20]  T. Akasaka,et al.  Hyperglycemia accelerated endothelial progenitor cell senescence via the activation of p38 mitogen-activated protein kinase. , 2006, Circulation journal : official journal of the Japanese Circulation Society.

[21]  T. Akasaka,et al.  Endothelial Progenitor Cell Differentiation and Senescence in an Angiotensin II-Infusion Rat Model , 2006, Hypertension Research.

[22]  J. Yodoi,et al.  17β-Estradiol Protects against Oxidative Stress-induced Cell Death through the Glutathione/Glutaredoxin-dependent Redox Regulation of Akt in Myocardiac H9c2 Cells* , 2006, Journal of Biological Chemistry.

[23]  Roberto Bolli,et al.  Life and Death of Cardiac Stem Cells: A Paradigm Shift in Cardiac Biology , 2006, Circulation.

[24]  T. Imanishi,et al.  Endothelial progenitor cell senescence is accelerated in both experimental hypertensive rats and patients with essential hypertension , 2005, Journal of hypertension.

[25]  T. Lange,et al.  Shelterin: the protein complex that shapes and safeguards human telomeres , 2005 .

[26]  G. Nickenig,et al.  Circulating endothelial progenitor cells and cardiovascular outcomes. , 2005, The New England journal of medicine.

[27]  T. Imanishi,et al.  Estrogen reduces endothelial progenitor cell senescence through augmentation of telomerase activity , 2005, Journal of hypertension.

[28]  T. Imanishi,et al.  Effect of Estrogen on Differentiation and Senescence in Endothelial Progenitor Cells Derived from Bone Marrow in Spontaneously Hypertensive Rats , 2005, Hypertension Research.

[29]  M. Barbacid,et al.  Tumour biology: Senescence in premalignant tumours , 2005, Nature.

[30]  J. Shay,et al.  BRAFE600-associated senescence-like cell cycle arrest of human naevi , 2005, Nature.

[31]  M. Blasco.  Telomeres and human disease: ageing, cancer and beyond , 2005, Nature Reviews Genetics.

[32]  S. Artandi,et al.  Pathways connecting telomeres and p53 in senescence, apoptosis, and cancer. , 2005, Biochemical and biophysical research communications.

[33]  S. Fichtlscherer,et al.  Reduced Number of Circulating Endothelial Progenitor Cells Predicts Future Cardiovascular Events: Proof of Concept for the Clinical Importance of Endogenous Vascular Repair , 2005, Circulation.

[34]  M. Kelm,et al.  Impaired progenitor cell activity in age-related endothelial dysfunction. , 2005, Journal of the American College of Cardiology.

[35]  J. Campisi.  Senescent Cells, Tumor Suppression, and Organismal Aging: Good Citizens, Bad Neighbors , 2005, Cell.

[36]  T. Lange,et al.  Significant Role for p16INK4a in p53-Independent Telomere-Directed Senescence , 2004, Current Biology.

[37]  Chaowei Wu,et al.  Regulation of cellular response to oncogenic and oxidative stress by Seladin-1 , 2004, Nature.

[38]  H. Drexler,et al.  Statin-Induced Improvement of Endothelial Progenitor Cell Mobilization, Myocardial Neovascularization, Left Ventricular Function, and Survival After Experimental Myocardial Infarction Requires Endothelial Nitric Oxide Synthase , 2004, Circulation.

[39]  M. Hristov,et al.  Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance , 2004, Journal of cellular and molecular medicine.

[40]  Leslie A. Smith,et al.  Transplantation of Circulating Endothelial Progenitor Cells Restores Endothelial Function of Denuded Rabbit Carotid Arteries , 2004, Stroke.

[41]  A. Zeiher,et al.  Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis? , 2004, Journal of Molecular Medicine.

[42]  T. Sawamura,et al.  OXIDIZED LOW‐DENSITY LIPOPROTEIN INDUCES ENDOTHELIAL PROGENITOR CELL SENESCENCE, LEADING TO CELLULAR DYSFUNCTION , 2004, Clinical and experimental pharmacology & physiology.

[43]  A. Akhmedov,et al.  Chronic oxidative stress compromises telomere integrity and accelerates the onset of senescence in human endothelial cells , 2004, Journal of Cell Science.

[44]  Mark A Sussman,et al.  Cardiac Stem Cell and Myocyte Aging, Heart Failure, and Insulin-Like Growth Factor-1 Overexpression , 2004, Circulation research.

[45]  M. Endres,et al.  Physical Training Increases Endothelial Progenitor Cells, Inhibits Neointima Formation, and Enhances Angiogenesis , 2004 .

[46]  Hajime Nakamura,et al.  Glutaredoxin Exerts an Antiapoptotic Effect by Regulating the Redox State of Akt* , 2003, Journal of Biological Chemistry.

[47]  C. Sugimoto,et al.  PI3K/Akt and apoptosis: size matters , 2003, Oncogene.

[48]  R. Mulligan,et al.  Isolation and Transplantation of Autologous Circulating Endothelial Cells Into Denuded Vessels and Prosthetic Grafts: Implications for Cell-Based Vascular Therapy , 2003, Circulation.

[49]  N. Kobayashi,et al.  Celiprolol Activates eNOS Through the PI3K-Akt Pathway and Inhibits VCAM-1 Via NF-&kgr;B Induced by Oxidative Stress , 2003, Hypertension.

[50]  K. Collins,et al.  Telomere maintenance and disease , 2003, The Lancet.

[51]  Pascal J. Goldschmidt-Clermont,et al.  Aging, Progenitor Cell Exhaustion, and Atherosclerosis , 2003, Circulation.

[52]  T. Jacks,et al.  Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry , 2003, Nature.

[53]  R. Brandes,et al.  Hydrogen Peroxide Triggers Nuclear Export of Telomerase Reverse Transcriptase via Src Kinase Family-Dependent Phosphorylation of Tyrosine 707 , 2003, Molecular and Cellular Biology.

[54]  W. Hofmann,et al.  HMG-CoA Reductase Inhibitors Reduce Senescence and Increase Proliferation of Endothelial Progenitor Cells via Regulation of Cell Cycle Regulatory Genes , 2003, Circulation research.

[55]  Arshed A. Quyyumi,et al.  Circulating Endothelial Progenitor Cells, Vascular Function, and Cardiovascular Risk , 2003 .

[56]  Goberdhan P Dimri,et al.  Control of the Replicative Life Span of Human Fibroblasts by p16 and the Polycomb Protein Bmi-1 , 2003, Molecular and Cellular Biology.

[57]  J. Isner,et al.  Constitutive Human Telomerase Reverse Transcriptase Expression Enhances Regenerative Properties of Endothelial Progenitor Cells , 2002, Circulation.

[58]  K. Shimada,et al.  Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial , 2002, The Lancet.

[59]  W. Hahn,et al.  A Two-Stage, p16INK4A- and p53-Dependent Keratinocyte Senescence Mechanism That Limits Replicative Potential Independent of Telomere Status , 2002, Molecular and Cellular Biology.

[60]  J. Isner,et al.  Statin Therapy Accelerates Reendothelialization: A Novel Effect Involving Mobilization and Incorporation of Bone Marrow-Derived Endothelial Progenitor Cells , 2002, Circulation.

[61]  K. Chayama,et al.  Endothelial function and oxidative stress in renovascular hypertension. , 2002, The New England journal of medicine.

[62]  G. Peters,et al.  INK4a‐deficient human diploid fibroblasts are resistant to RAS‐induced senescence , 2002, The EMBO journal.

[63]  M. Makuuchi,et al.  Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis , 2002, Nature Medicine.

[64]  A. Lloyd,et al.  Milestones in cell division: Cell senescence and cancer , 2001, Nature Reviews Cancer.

[65]  T. Meinertz,et al.  Endothelial Dysfunction, Oxidative Stress, and Risk of Cardiovascular Events in Patients With Coronary Artery Disease , 2001, Circulation.

[66]  D. Carrasco,et al.  Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis , 2001, Nature.

[67]  S. Fichtlscherer,et al.  Number and Migratory Activity of Circulating Endothelial Progenitor Cells Inversely Correlate With Risk Factors for Coronary Artery Disease , 2001, Circulation research.

[68]  F. Perticone,et al.  Prognostic Significance of Endothelial Dysfunction in Hypertensive Patients , 2001, Circulation.

[69]  A. Zeiher,et al.  Pro‐atherogenic factors induce telomerase inactivation in endothelial cells through an Akt‐dependent mechanism , 2001, FEBS letters.

[70]  J. Shay,et al.  Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions. , 2001, Genes & development.

[71]  D. Harrison,et al.  Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. , 2000, Circulation research.

[72]  S. Elledge,et al.  Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. , 2000, Genes & development.

[73]  I. Sayek,et al.  Coenzyme Q10 concentrations and antioxidant status in tissues of breast cancer patients. , 2000, Clinical biochemistry.

[74]  J. Slingerland,et al.  p16INK4A mediates cyclin dependent kinase 4 and 6 inhibition in senescent prostatic epithelial cells. , 2000, Cancer research.

[75]  J. Isner,et al.  Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[76]  Hiroshi Takahashi,et al.  Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor-directed interferon , 1999, Nature Medicine.

[77]  Haruchika Masuda,et al.  Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization , 1999, Nature Medicine.

[78]  R. DePinho,et al.  The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus , 1999, Nature.

[79]  R. Ross,et al.  Atherosclerosis is an inflammatory disease. , 1998, American heart journal.

[80]  T. Kiyono,et al.  Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells , 1998, Nature.

[81]  E. Hiyama,et al.  Age-dependent telomere shortening is slowed down by enrichment of intracellular vitamin C via suppression of oxidative stress. , 1998, Life sciences.

[82]  R. Schmieder,et al.  Increased bioavailability of nitric oxide after lipid-lowering therapy in hypercholesterolemic patients: a randomized, placebo-controlled, double-blind study. , 1998, Circulation.

[83]  R. DePinho,et al.  Essential role of mouse telomerase in highly proliferative organs , 1998, Nature.

[84]  C. Harley,et al.  Extension of life-span by introduction of telomerase into normal human cells. , 1998, Science.

[85]  C. D. Edwards,et al.  p16INK4A Participates in a G1 Arrest Checkpoint in Response to DNA Damage , 1998, Molecular and Cellular Biology.

[86]  D. Green,et al.  Improvement in endothelial function by angiotensin converting enzyme inhibition in insulin-dependent diabetes mellitus. , 1997, The Journal of clinical investigation.

[87]  M. Mandal,et al.  Cell cycle-dependent modulation of telomerase activity in tumor cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[88]  J. Yodoi,et al.  Persistent oxidative stress in cancer , 1995, FEBS letters.

[89]  C. Harley,et al.  Telomeres shorten during ageing of human fibroblasts , 1990, Nature.

[90]  R. Ross,et al.  The pathogenesis of atherosclerosis (first of two parts). , 1976, The New England journal of medicine.